Suppr超能文献

相似文献

1
Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors.
J Neurol Neurosurg Psychiatry. 1999 Aug;67(2):148-52. doi: 10.1136/jnnp.67.2.148.
2
Natural history of benign multiple sclerosis: Clinical and HLA correlates in a Western Australian cohort.
J Neurol Sci. 2018 May 15;388:12-18. doi: 10.1016/j.jns.2018.02.036. Epub 2018 Feb 22.
3
Longitudinal follow-up of "benign" multiple sclerosis at 20 years.
Neurology. 2007 Feb 13;68(7):496-500. doi: 10.1212/01.wnl.0000253185.03943.66.
4
Clinical features and disability progression in multiple sclerosis in Tunisia: do we really have a more aggressive disease course?
J Neurol Sci. 2014 Aug 15;343(1-2):110-4. doi: 10.1016/j.jns.2014.05.049. Epub 2014 Jun 2.
5
Clinical characteristics and long term prognosis in early onset multiple sclerosis.
J Neurol. 2006 Jun;253(6):720-3. doi: 10.1007/s00415-006-0095-1. Epub 2006 Mar 6.
6
Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK.
J Neurol Neurosurg Psychiatry. 1998 Apr;64(4):451-4. doi: 10.1136/jnnp.64.4.451.
8
Is late-onset multiple sclerosis associated with a worse outcome?
Neurology. 2006 Sep 26;67(6):954-9. doi: 10.1212/01.wnl.0000237475.01655.9d.
9
Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study.
J Neurol. 2017 Jun;264(6):1068-1075. doi: 10.1007/s00415-017-8487-y. Epub 2017 Apr 17.
10
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
Lancet Neurol. 2016 May;15(6):574-84. doi: 10.1016/S1474-4422(16)00068-5. Epub 2016 Mar 18.

引用本文的文献

2
Sex-chromosome complement and Activin-A shape the therapeutic potential of TNFR2 activation in a model of MS and CNP.
Proc Natl Acad Sci U S A. 2025 May 20;122(20):e2426771122. doi: 10.1073/pnas.2426771122. Epub 2025 May 16.
3
Validation of the Patient-Determined Disease Steps in ambulatory older adults with multiple sclerosis.
Mult Scler Relat Disord. 2025 May;97:106391. doi: 10.1016/j.msard.2025.106391. Epub 2025 Mar 15.
6
Alemtuzumab for multiple sclerosis.
Cochrane Database Syst Rev. 2023 Jun 5;6(6):CD011203. doi: 10.1002/14651858.CD011203.pub3.
7
Potential biological contributers to the sex difference in multiple sclerosis progression.
Front Immunol. 2023 Apr 14;14:1175874. doi: 10.3389/fimmu.2023.1175874. eCollection 2023.

本文引用的文献

2
PROGNOSTIC CRITERIA IN MULTIPLE SCLEROSIS.
Ann N Y Acad Sci. 1965 Mar 31;122:542-51. doi: 10.1111/j.1749-6632.1965.tb20234.x.
3
THE BENIGN FORM OF MULTIPLE SCLEROSIS: RESULTS OF A LONG-TERM STUDY.
Br Med J. 1964 Oct 24;2(5416):1029-32. doi: 10.1136/bmj.2.5416.1029.
5
The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up.
Brain. 1998 Mar;121 ( Pt 3):495-503. doi: 10.1093/brain/121.3.495.
6
An epidemiologic study of multiple sclerosis in Northern Ireland.
Neurology. 1998 Feb;50(2):423-8. doi: 10.1212/wnl.50.2.423.
8
A population-based study of multiple sclerosis in twins: update.
Ann Neurol. 1993 Mar;33(3):281-5. doi: 10.1002/ana.410330309.
9
Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up.
Brain. 1993 Feb;116 ( Pt 1):117-34. doi: 10.1093/brain/116.1.117.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验